# q08 rev 1 raw returns (tested_sha256 3092761169e979e14ed727f83821d22ba36dd43cc3bbeaa3d0565c7451da2c1b)

Fresh agents dispatched 2026-10-06 by the caller (Claude Code, Opus 5.5) with only the workspace
root, their own packet path and the verbatim question (closed-book: question only). Returns are
copied verbatim from the task notifications.

## Blind solver A (blind-solver, packet solver-1)

**answer:** −$0.10. The low end fell from $5.55 to $5.45.

**confidence:** high

**path:**
1. **When the acquisition closed.** D08 (Apr 16, 2026 release), line 27: "On March 23, 2026, Abbott completed its acquisition of Exact Sciences". D10, lines 49 and 685, gives the same date: "Exact Sciences was acquired by Abbott on March 23, 2026."
2. **Range in force on March 23, 2026.** D07 (Jan 22, 2026), lines 31 and 335: "Abbott projects full-year 2026 adjusted diluted earnings per share of $5.55 to $5.80". The next range only came out on April 16, after the close. D08's headline (line 15) is "Updates Guidance to Reflect Acquisition of Exact Sciences", and lines 19, 31 and 223 give "$5.38 to $5.58, which includes $0.20 of dilution related to the acquisition of Exact Sciences." So the low end on March 23 was **$5.55**.
3. **The dividend declared in June 2026.** D10 (Jul 16, 2026), line 337: "On June 12, 2026, the board of directors of Abbott declared the company's quarterly dividend of $0.63 per share. Abbott's cash dividend is payable Aug. 17, 2026". The payment date is therefore **Aug 17, 2026**.
4. **Range in force on Aug 17, 2026.** D10, lines 19 and 29: "Abbott raises full-year 2026 adjusted diluted EPS guidance range to $5.45 to $5.60, compared to previous range of $5.38 to $5.58". Line 329 repeats "$5.45 to $5.60". The only later document, D11 (Aug 20, 2026), is about settling litigation over preterm infant formula. It contains no guidance and comes after Aug 17 anyway. So the low end on Aug 17 was **$5.45**.
5. **Calculation.** $5.45 − $5.55 = **−$0.10**.
6. The figures in the original docs/ files match the text/ versions (same number of matching lines in each of the three source files).

The full sequence was $5.55 (Jan 22), then $5.38 (Apr 16), then $5.45 (Jul 16). The net change over the period is −$0.10.

**minimal_documents:** D07, D08, D10.
- D07 gives the January range.
- D08 dates the $5.38–$5.58 range to April 16, after the March 23 close. Without it, D10's "previous range" can't be placed relative to the close date. D08 also gives the close date.
- D10 gives the dividend dates and the July range, and could replace D08 for the close date only.
- No other document in the packet can stand in for D07 or D10.

**readings:**
- If "the range in force when it completed its acquisition" is read as the first range issued after the deal closed ($5.38, from Apr 16), the answer is **+$0.07**. This reading is weaker because that range came out 24 days after the close.
- If the declaration date (Jun 12) were used instead of the payment date, the range in force would be $5.38–$5.58, giving −$0.17. The question specifies the payment date, so this reading doesn't apply.

**gaps:**
- "In force" depends on there being no guidance updates outside the packet. The packet has no Abbott document between Jan 22 and Apr 16, 2026, or between Jul 16 and Aug 17, 2026. D08 does not state the previous range in words, although its headline indicates that April 16 was when guidance changed.
- The packet has no PDFs or layout files (the manifest marks every document as "text" with no pages), so there was nothing to check visually.
- Reading coverage:
  - Read in full: D09 (notice of a shareholder lawsuit settlement) and D11.
  - Read in part: D07, D08 and D10 (headlines and guidance sections), D05 (lines 13–52), and D06 (header only; it is the company bylaws).
  - Covered by keyword searches only: D01–D04 (2025 guidance).
- I did not read question.txt.

**contaminated:** no

Files: D:\Dev\Docket\tasks\aq-00745\runs\q08-r1-v2-3092761169e979e14ed727f83821d22ba36dd43cc3bbeaa3d0565c7451da2c1b\solver-1\text\D07.txt, ...\text\D08.txt, ...\text\D10.txt

## Blind solver B (blind-solver, packet solver-2)

answer: −$0.10. The low end fell by 10 cents, from $5.55 to $5.45.

confidence: high

path:
1. **Range in force when the acquisition closed.** D07 (Jan. 22, 2026), line 31: "Abbott projects full-year 2026 adjusted diluted EPS of $5.55 to $5.80, which reflects growth of 10 percent at the midpoint." The guidance section at line 335 repeats it: "...adjusted diluted earnings per share of $5.55 to $5.80..."
2. **Closing date.** D08 (Apr. 16, 2026), line 27: "On March 23, 2026, Abbott completed its acquisition of Exact Sciences." D10 lines 49, 203, 685 and 722 give the same date.
3. **Next guidance change came after closing.** D08 headline (line 15): "Updates Guidance to Reflect Acquisition of Exact Sciences." Line 223: "...$5.38 to $5.58, which includes $0.20 of dilution related to the acquisition of Exact Sciences." This was issued April 16, after March 23. No document in the packet changes the guidance between Jan. 22 and Mar. 23, so $5.55–$5.80 was in force on March 23. Low end: $5.55.
4. **The June 2026 dividend.** D10, line 337: "On June 12, 2026, the board of directors of Abbott declared the company's quarterly dividend of $0.63 per share. Abbott's cash dividend is payable Aug. 17, 2026, to shareholders of record at the close of business on July 15, 2026."
5. **Range in force on Aug. 17, 2026.** D10 (July 16, 2026), line 29: "Abbott raises full-year 2026 adjusted diluted EPS guidance range to $5.45 to $5.60, compared to previous range of $5.38 to $5.58." Line 329 confirms "$5.45 to $5.60." The only later document, D11 (Aug. 20, 2026, an infant-formula litigation settlement), contains no guidance and is dated after Aug. 17 anyway. Low end: $5.45.
6. **Calculation.** $5.45 − $5.55 = −$0.10.

The full sequence of low ends is $5.55 (Jan.), then $5.38 (Apr.), then $5.45 (Jul.). The net change from closing to the payment date is −$0.10.

minimal_documents: D07, D08, D10.
- D07 gives the January range.
- D08 dates the first post-closing update to April 16, which shows the January range still applied on March 23. D10 alone can't do this: its "previous range of $5.38 to $5.58" has no issue date.
- D10 gives the dividend payment date and the July range.
- No replacement for D07 or D08 exists. D08 is the only source for the April 16 issue date, and D07 is the only source for $5.55. The closing date could come from either D08 or D10.

readings:
- **Range "reflecting" the acquisition as the starting point:** If the starting range is taken as the first one that reflected the acquisition (D08's $5.38), the change is +$0.07. This reading doesn't fit "in force when it completed," because that range was issued 24 days after closing.
- **Declaration date instead of payment date:** On June 12, 2026 the April range ($5.38–$5.58) was in force, giving −$0.17. The question specifies the payment date, so this doesn't apply.
- **June 2025 dividend:** D03 has a June 13, 2025 dividend (payable Aug. 15, 2025). The question says June 2026, so it doesn't apply.

gaps:
- **No outside updates checked.** The conclusion that no other guidance change occurred (Jan. 22–Mar. 23 and Jul. 16–Aug. 17) rests on what the packet contains. A search of both `text\` and `docs\` for full-year 2026 guidance terms found hits only in D07, D08 and D10. No outside sources were checked.
- **Files read partly.** I read D09 and D11 in full. I read the headlines, guidance and dividend sections of D07, D08 and D10. I searched rather than read D01–D06. D01–D04 are 2025 earnings releases, D05 is the Nov. 2025 deal announcement with no EPS guidance, and D06 is the by-laws.
- **No extraction problems.** All sources are plain text, with no PDFs or layout files.
- I did not read `question.txt`.

contaminated: no

## Closed-book solver (question only, no tools used)

answer: -$0.17 (I think the low end fell from about $5.55 to about $5.38)

confidence: low

basis: This is from memory only. I'm moderately sure Abbott's January 2026 guidance for full-year 2026 adjusted diluted EPS was $5.55–$5.80. I think that range was still in force when the Exact Sciences deal closed, which I believe was around Q1 2026. The dividend declared in June 2026 would have been paid about August 15, 2026, so the range in force then would come from the Q2 update in July 2026. That update is past what I can reliably recall. I have only a faint memory of a later range, after the Exact dilution of roughly $0.20, with a low end near $5.38. If the July update raised the low end, the change would be smaller, perhaps -$0.12 to -$0.15.

contaminated: no (only automatic account and environment details were attached, nothing about the question)

## Shortcut auditor (shortcut-auditor, packet shortcut)

answer: −$0.10. The low end fell from $5.55 to $5.45.

verdict: clear

shortest_path:
1. **Completion date.** D08 (Apr. 16, 2026), line 27: "On March 23, 2026, Abbott completed its acquisition of Exact Sciences". D10 lines 49 and 203 give the same date.
2. **Range on March 23, 2026.** D07 (Jan. 22, 2026), lines 31 and 335: "Abbott projects full-year 2026 adjusted diluted earnings per share of $5.55 to $5.80". The next change is D08, headlined "Updates Guidance to Reflect Acquisition of Exact Sciences", which sets "$5.38 to $5.58, which includes $0.20 of dilution related to the acquisition of Exact Sciences" (line 223). That change came on April 16, after the closing. So the range in force at completion was $5.55 to $5.80, and its low end is **$5.55**.
3. **The June 2026 dividend.** D10, line 337: "On June 12, 2026, the board of directors of Abbott declared the company's quarterly dividend of $0.63 per share. Abbott's cash dividend is payable Aug. 17, 2026, to shareholders of record at the close of business on July 15, 2026."
4. **Range on Aug. 17, 2026.** D10 (July 16, 2026), line 29: "Abbott raises full-year 2026 adjusted diluted EPS guidance range to $5.45 to $5.60, compared to previous range of $5.38 to $5.58." D11 (Aug. 20, 2026) is a litigation-settlement release with no guidance change, and it comes after the payment date anyway. The low end is **$5.45**.
5. **Calculation.** $5.45 − $5.55 = **−$0.10**.

sufficient_documents: D07 + D08 + D10.
- D07 is the only document that contains $5.55 / $5.80; neither D08 nor D10 repeats the January range.
- D08 is needed to show the move to $5.38–$5.58 happened after March 23.
- D10 supplies the dividend, the payment date and the range in force on that date.
- The completion date is in either D08 or D10.
- No single document holds both endpoints.

searches:
- **Terms searched:**
  - "Exact Sciences"
  - "dividend"
  - "guidance", "projects full-year", "full-year 2026"
  - "accreti", "dilution", "dilutive", "EPS", "$5.xx"
  - "previous", "previously", "reaffirm", "5.55", "5.80", "prior range", "initial guidance"
- **Read in detail:**
  - D07, D08 and D10: headlines, guidance sections and dividend sections.
  - D05 (Nov. 20, 2025 deal announcement): says the deal is "immediately accretive to Abbott's revenue growth and gross margin", with no EPS guidance.
  - D06: amended by-laws dated Dec. 12, 2025.
  - D09: notice of a derivative-suit settlement, dated Apr. 17, 2026.
  - D11: preterm-formula (NEC) settlement release, dated Aug. 20, 2026.
- **Seen through search hits only:** D01–D04 hold 2025 guidance and 2025 dividends (including a June 13, 2025 dividend payable Aug. 15, 2025, which is the wrong year).
- **Originals:** the key lines in the docs/ files match the text extraction (11 hits across the 2026-01-22, 2026-04-16 and 2026-07-16 files).
- question.txt was not opened.

readings/gaps:
- **Using D08's post-closing range as the one "in force at completion":** $5.45 − $5.38 = **+$0.07**. A reader of D10 alone ("compared to previous range of $5.38 to $5.58") lands here. It is wrong because D08 was issued April 16, after the March 23 closing.
- **Using the record date (July 15, 2026) or declaration date (June 12, 2026) instead of the payment date:** the range in force is $5.38–$5.58, giving **−$0.17**. The record date falls one day before the July 16 raise, so this is a sensitive point, but the question clearly says "payment date".
- **Making both mistakes:** **$0.00**.
- **Gap:** the packet has no document between Jan. 22 and Apr. 16, 2026, so a guidance change at closing that isn't in the packet cannot be ruled out. D08's headline "Updates Guidance to Reflect Acquisition of Exact Sciences", and the $0.20 dilution first appearing there, suggest no earlier change.
- **Difficulty risk:** the route is a simple three-document lookup plus one subtraction. The "previous range" wording in D10 and the record-date versus payment-date distinction are what separate careful readers. No shortcut was found that gives the correct whole answer.

Key files:
- D:\Dev\Docket\tasks\aq-00745\runs\q08-r1-v2-3092761169e979e14ed727f83821d22ba36dd43cc3bbeaa3d0565c7451da2c1b\shortcut\text\D07.txt
- D:\Dev\Docket\tasks\aq-00745\runs\q08-r1-v2-3092761169e979e14ed727f83821d22ba36dd43cc3bbeaa3d0565c7451da2c1b\shortcut\text\D08.txt
- D:\Dev\Docket\tasks\aq-00745\runs\q08-r1-v2-3092761169e979e14ed727f83821d22ba36dd43cc3bbeaa3d0565c7451da2c1b\shortcut\text\D10.txt
- D:\Dev\Docket\tasks\aq-00745\runs\q08-r1-v2-3092761169e979e14ed727f83821d22ba36dd43cc3bbeaa3d0565c7451da2c1b\shortcut\text\D11.txt
